drugset / Trial / NCT03571087
Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of HL140 in patients with primary hypercholesterolemia.
Timeline
- Start
- 2014-09
- Primary completion
- 2015-08
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ezetimibe | Unknown | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 5 mg | — |
| Subject | Rosuvastatin | Small molecule | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |